Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
The retinal implant at the back of the eye. Source: OU
The retinal implant at the back of the eye. Source: OU

Professor Robert MacLaren, Nuffield Laboratory of Ophthalmology, has performed the first retinal implant in the UK, performing the eight hour surgery at the Oxford University Hospitals NHS Trust. The patient, Chris James, had been left completely blind from retinitis pigmentosa, a disease in which retinal cells deteriorate over time. The retinal implants contain 1500 electronic light detectors which act as substitutes for the lost retinal cells. The implant’s electrodes are connected to overlying nerves which relay signals to the optic nerve, with the patient experiencing a pixelated image. A power supply for the device is inserted behind the ear.

Once the implant was switched on, the patient was able to immediately detect light. After some time adjusting to the device, he is now able to recognise basic shape outlines. The device is still in the trial phase, with up to 12 UK patients being included. The manufacturers, Retina Implant of Germany, hope for commercial approval following the trial.

Prof MacLaren said ‘we are all delighted with these initial results. The vision is different to normal ... and it requires a different type of brain processing. We hope, however, that the electronic chips will provide independence for many people who are blind from retinitis pigmentosa.’

Similar stories

New insights into the effect of exposure to dim light in the evening on the biology of the sleep-wake cycle

A new study has revealed more about how exposure to dim light in the evening affects circadian health. The findings emphasise the need to optimise our artificial light exposure if we are to avoid shifting our biological clocks.

Blood lipoprotein levels linked to future risk of amyotrophic lateral sclerosis

Greater understanding of the role of lipoproteins could support screening and efforts to develop treatments.

International study finds insomnia, anxiety and depression very prevalent during first phase of COVID-19 pandemic

Researchers are recommending public health interventions to reduce the long-term adverse outcomes associated with chronic insomnia and mental health problems.

Alexander Davies wins top UKRI Future Leaders Fellowship

Alex is one of eight Oxford University academics who have been awarded significant financial funding from the UKRI Future Leaders Fellowships Scheme

New study on link between autoimmunity and pain

Patients with autoantibodies which target neuronal proteins can have pain as an under-recognised clinical manifestation.